<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 11 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
h1
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
h3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.XNotesHeading, li.XNotesHeading, div.XNotesHeading
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";
	font-weight:bold;}
p.XNotes, li.XNotes, div.XNotes
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Constitution, li.Constitution, div.Constitution
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1Paragraph, li.1Paragraph, div.1Paragraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.aSubsection, li.aSubsection, div.aSubsection
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraph, li.ASubparagraph, div.ASubparagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.iClause, li.iClause, div.iClause
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-indent:-2.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraphContd, li.ASubparagraphContd, div.ASubparagraphContd
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1ParagraphContd, li.1ParagraphContd, div.1ParagraphContd
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.RegularParagraphs, li.RegularParagraphs, div.RegularParagraphs
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Style1, li.Style1, div.Style1
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
 /* Page Definitions */
 @page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.Section1
	{page:Section1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=Section1>

<p class=RegularParagraphs>     <b>[§325-116]  Reports.</b>  The department, on
or before January&nbsp;1 of each year, shall submit a report to the oversight
committee.  The report shall include:</p>

<p class=1Paragraph>     (1)  Information as to the number of participants
served and the number of needles and syringes distributed;</p>

<p class=1Paragraph>     (2)  A demographic profile of the participants served,
including but not limited to: <b> </b>age, sex, ethnicity, area of residence,
occupation, types of drugs used, length of drug use, and frequency of
injection;</p>

<p class=1Paragraph>     (3)  Impact of the program on needle and syringe
sharing and other high risk behavior;</p>

<p class=1Paragraph>     (4)  Data on participants regarding HIV testing,
counseling, drug treatment, and other social services, including referrals for
HIV testing and counseling and for drug abuse treatment;</p>

<p class=1Paragraph>     (5)  Impact on the transmission of HIV infection among
injection drug users;</p>

<p class=1Paragraph>     (6)  Impact on behaviors that caused participants to
be at risk for HIV transmission such as frequency of drug use and needle
sharing;</p>

<p class=1Paragraph>     (7)  An assessment of the cost-effectiveness of the
program versus direct and indirect costs of HIV infection; and</p>

<p class=1Paragraph>     (8)  Information on the percentage of persons served
through treatment programs for injection drug users funded through the
department that were attributed to needle exchange referrals.</p>

<p class=RegularParagraphs>     The report shall address the strengths and
weaknesses of the program, the advisability of its continuation, amendments to
the law, if appropriate, and other matters that may be helpful to the oversight
committee in evaluating the program's efficacy.<b> </b>[L 1992, c 152, pt of
§2]</p>

<p class=RegularParagraphs>&nbsp;</p>

</div>

</body>

</html>
<center><table border="0" width="90%"><tr>
<td align="left"><a href="/hrs2007/Vol06_Ch0321-0344/HRS0325/HRS_0325-0115.htm">Previous</a></td>
<td align="center"><a href=/hrs2007/Vol06_Ch0321-0344>Vol06_Ch0321-0344</a></td>
<td align="right"><a href="/hrs2007/Vol06_Ch0321-0344/HRS0325/HRS_0325-0117.htm">Next</a></td>
</tr></table></center>
